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(BMP)	 pathway	 using	 CRISPR/Cas9	 genome	 editing.	 In	 principle,	 our	methodology	 can	 be	
applied	 to	 any	 cell	 line.	 The	 endogenous	 reporters	 will	 provide	 a	 robust	 system	 for	 the	





(TGFβ)	 superfamily	 of	 cytokines,	 with	 crucial	 roles	 in	 embryogenesis	 and	 adult	 tissue	
homeostasis.	 Aberrant	 BMP	 signaling	 is	 thus	 associated	 with	 numerous	 developmental	
defects	 and	 human	 pathologies	 (2).	 BMPs	 signal	 via	 binding	 to	 and	 activation	 of	 cognate	
type	 I	 and	 type	 II	 BMP	 receptor	 serine/threonine	 kinases.	 The	 activated	 type	 I	 BMP	
receptors	subsequently	phosphorylate	the	intracellular	SMAD	transcription	factors	1,	5	and	
8	 at	 a	 C-terminal	 Ser-X-Ser	 motif,	 thereby	 inducing	 their	 interaction	 with	 the	 common	
mediator	 SMAD4.	 The	 SMAD1/5/8-SMAD4	 complex	 is	 then	 able	 to	 translocate	 into	 the	
nucleus,	 where	 it	 associates	 with	 various	 transcriptional	 co-factors	 to	 regulate	 gene	
expression	 (3).	 Inhibitor	 of	 differentiation	1	 (ID-1),	 a	 dominant	 negative	 regulator	 of	 basic	
helix-loop-helix	 (bHLH)	 transcription	 factors,	 is	 a	 direct	 gene	 target	 of	 BMP	 signaling	 (4).	







reporter	cassette	containing	 firefly	 luciferase	 and	GFP	 gene,	has	been	 inserted	adjacent	 to	
the	endogenous	 ID-1	 promoter	 sequence.	The	generation	of	 the	 cell	 line	 thus	enables	 the	







































A	 dual	 guide	 RNA	 (gRNA)	 approach	 was	 undertaken	 with	 sense	 and	 antisense	 gRNAs	
designed	 to	 target	 a	 region	 (corresponding	 to	 nucleotides	 41-84)	 within	 the	 N-terminal	
coding	region	of	the	ID-1	gene.	
	
• Sense	 gRNA	 (5’-CGGCAAGACAGCGAGCGGTGCGG-3’)	 cloned	 into	 pBABE-Puro	 U6	
vector	containing	puromycin	resistance	sequence	









• Complementary	 DNA	 (cDNA)	 sequences	 encoding	 for	 firefly	 luciferase	 and	 green	
fluorescent	protein	(GFP)	
	
• Two	 regions	 (approximately	 500	 nucleotides)	 homologous	 to	 the	 ID-1	 gene	 locus	
around	 the	 start	 codon,	 located	 upstream	 and	 downstream	 of	 the	 cassette,	 to	
facilitate	homologous	recombination	
	
• Silent	mutations	were	 included	 in	 the	 downstream	homologous	 region	 to	 prevent	
cleavage	by	the	gRNA-directed	Cas9	nuclease	
	
• An	 internal	 ribosome	 entry	 site	 (IRES)	 element	 was	 incorporated	 immediately	







Immortalized	human	 keratinocyte	HaCaT	 cells	were	 cultured	 in	Dulbecco’s	Modified	 Eagle	
Medium	(DMEM)	supplemented	with	10%	(v/v)	fetal	bovine	serum	(FBS),	2	mM	L-glutamine,	




















and	 allow	 the	 cells	 to	 recover	 for	 24	 hours	 (Optional:	 in	 order	 to	 increase	 the	
efficiency	 of	 homologous	 recombination,	 perform	 a	 repeat	 transfection	 and	
antibiotic	selection	on	the	same	cells	following	an	identical	procedure).	
	


























7. Cells	were	 allowed	 to	 proliferate	 and	 transferred	 into	 progressively	 larger	 surface	





activity	 compared	 to	 control	 cells	were	 subsequently	 analysed	 for	 responsiveness	 to	 BMP	
stimulation.	
	




deprivation	 minimizes	 basal	 autocrine	 growth	 factor/cytokine	 signalling,	 thereby	






4. The	 BMP	 type	 I	 receptor	 (ALK2/3)	 inhibitor	 LDN-193189	 can	 used	 at	 100	 nM	




5. Aspirate	 serum-free	 DMEM	 and	 dispense	 2	 mL	 of	 each	 cytokine	 and/or	 inhibitor	
combination	 into	 the	 appropriate	 well.	 Incubate	 for	 6-8	 hours	 at	 37°C	 (Note:	 6-8	













well	 in	 a	 6-well	 cell	 culture	 plate)	 and	 incubate	 cells	 for	 5-10	 minutes	 at	 room	
temperature	with	gentle	agitation	in	a	shaker.	
	
4. Scrape	 the	 cells	 from	 the	 plate	 surface	 and	 transfer	 lysates	 into	 1.5	 mL	
microcentrifuge	tubes	on	ice.	
	
5. Vortex	 the	 cell	 lysates	 for	 10-15	 seconds	 and	 then	 centrifuge	 at	 12,000	 x	 g	 for	 2	
minutes	at	4°C.	Transfer	the	supernatant	into	new	1.5	mL	microcentrifuge	tubes	
	
6. Dispense	40	µL	of	clarified	cell	 lysate	per	well	of	a	96-well	microplate	 (in	 triplicate	
for	 each	 condition)	 and	 subsequently	 add	 an	 equal	 volume	of	 2x	 Luciferase	Assay	
Buffer	per	well.	
	
7. Seal	 the	 microplate	 with	 adherent	 sealing	 tape	 and	 place	 the	 microplate	 on	 a	
vibrating	platform	for	30-60	seconds.	Immediately	obtain	luminescence	values	using	
a	microplate	 reader.	 (Note:	 It	 is	very	 important	 to	minimise	 the	 time	between	the	
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